Aptus Capital Advisors LLC bought a new stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,282 shares of the company's stock, valued at approximately $511,000.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new stake in Nutrien in the fourth quarter worth $241,958,000. Arrowstreet Capital Limited Partnership grew its position in shares of Nutrien by 159.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company's stock worth $242,976,000 after acquiring an additional 3,341,169 shares during the last quarter. ARGA Investment Management LP increased its holdings in shares of Nutrien by 25.7% in the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company's stock worth $270,396,000 after acquiring an additional 1,236,671 shares during the period. Silchester International Investors LLP lifted its position in Nutrien by 9.5% in the 4th quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company's stock valued at $523,268,000 after purchasing an additional 1,009,895 shares during the last quarter. Finally, Barclays PLC boosted its stake in Nutrien by 192.7% during the 4th quarter. Barclays PLC now owns 411,056 shares of the company's stock valued at $18,395,000 after purchasing an additional 854,543 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Price Performance
Shares of NTR traded up $0.84 during trading hours on Friday, hitting $55.59. 1,998,847 shares of the company were exchanged, compared to its average volume of 2,128,878. The firm has a fifty day simple moving average of $51.97 and a 200-day simple moving average of $49.96. The company has a market capitalization of $27.14 billion, a PE ratio of 40.58, a PEG ratio of 1.19 and a beta of 0.79. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien Ltd. has a one year low of $43.70 and a one year high of $60.87.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.35 by ($0.24). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The company had revenue of $4.67 billion during the quarter, compared to analysts' expectations of $5.16 billion. During the same period in the prior year, the business posted $0.46 EPS. The company's revenue for the quarter was down 5.4% compared to the same quarter last year. As a group, sell-side analysts predict that Nutrien Ltd. will post 3.72 earnings per share for the current year.
Nutrien Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 18th. Investors of record on Monday, June 30th will be given a $0.545 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.18 annualized dividend and a dividend yield of 3.92%. Nutrien's dividend payout ratio (DPR) is presently 203.74%.
Analyst Ratings Changes
Several brokerages have commented on NTR. Mizuho raised their price target on shares of Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a research note on Thursday, February 20th. Scotiabank boosted their price target on Nutrien from $60.00 to $62.00 and gave the stock a "sector outperform" rating in a research report on Monday, February 24th. CIBC increased their price target on Nutrien from $64.00 to $66.00 and gave the stock an "outperformer" rating in a research note on Tuesday, February 25th. Royal Bank of Canada restated an "outperform" rating and set a $60.00 price objective on shares of Nutrien in a research note on Monday, February 24th. Finally, Wells Fargo & Company increased their target price on shares of Nutrien from $53.00 to $56.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Two research analysts have rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $59.93.
View Our Latest Analysis on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Stories
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
